BioNTech SE (BNTX) Treasury Shares (2019 - 2024)
BioNTech SE's Treasury Shares history spans 6 years, with the latest figure at $9.2 million for Q4 2024.
- For Q4 2024, Treasury Shares fell 20.91% year-over-year to $9.2 million; the TTM value through Dec 2024 reached $9.2 million, down 20.91%, while the annual FY2024 figure was $9.3 million, 20.32% down from the prior year.
- Treasury Shares for Q4 2024 was $9.2 million at BioNTech SE, down from $11.6 million in the prior quarter.
- Across five years, Treasury Shares topped out at $11.6 million in Q4 2023 and bottomed at $4.3 million in Q4 2021.
- The 5-year median for Treasury Shares is $5.7 million (2020), against an average of $7.3 million.
- The largest annual shift saw Treasury Shares decreased 24.04% in 2021 before it surged 114.9% in 2023.
- A 5-year view of Treasury Shares shows it stood at $5.7 million in 2020, then fell by 24.04% to $4.3 million in 2021, then grew by 24.39% to $5.4 million in 2022, then skyrocketed by 114.9% to $11.6 million in 2023, then dropped by 20.91% to $9.2 million in 2024.
- Per Business Quant, the three most recent readings for BNTX's Treasury Shares are $9.2 million (Q4 2024), $11.6 million (Q4 2023), and $5.4 million (Q4 2022).